Caspr Biotech, headquartered in Buenos Aires, Argentina, and San Francisco, United States, specializes in advanced molecular diagnostics using proprietary CRISPR technology. The company serves a diverse range of clients, including healthcare providers, agricultural businesses, and industrial sectors. Operating in the biotechnology market, Caspr Biotech aims to democratize diagnostics by making precision diagnostics accessible to patients, healthcare facilities, and industries alike. The business model revolves around the development and commercialization of diagnostic tools that can be used in various settings, from hospitals and pharmacies to agricultural fields and industrial sites. Revenue is generated through the sale of diagnostic kits, licensing of their proprietary technology, and partnerships with industry stakeholders. Caspr Biotech's innovative approach ensures time-critical results, enhancing medical care and operational efficiency across different sectors.

Keywords: CRISPR, diagnostics, healthcare, agriculture, industrial, molecular detection, biotechnology, precision diagnostics, proprietary technology, biodiscovery.